Tag Archives: Merck

Pharma Layoffs Continue

By Cassandra Blohowiak | Published: March 4, 2009
It’s been another tough few weeks for pharma employees as four more companies handed out pink slips in an effort to trim bottom lines. Elan cut 14 percent of its global work force last Wednesday as a part of an ongoing strategic review process. The company announced that it would postpone biologics manufacturing, redesign R&D in [...]
Posted in Strategy | Also tagged , , , , , | 1 Comment

JP Morgan Healthcare Conference:
It’s All About "Money…Rather the Economy!"

By Audrey Erbes | Published: January 15, 2009
JP Morgan’s Healthcare Conference has always been about financing, but money has never been the main focus like it is at this year’s annual gathering in San Francisco. The hallmark of this investment meeting has been innovation, with companies passionately pitching their new product or technology and management team’s capability to execute on a [...]
Posted in Events | Also tagged , , , , , , , , , , , | 1 Comment

FDA Declares: Keep Taking Your Vytorin

By George Koroneos | Published: January 9, 2009
It’s official. Vytorin (ezetimibe/simvastatin) still does what it’s supposed to do—significantly decrease LDL cholesterol. FDA, yesterday, released its assessment of the now-notorious ENHANCE trial—which tested whether Vytorin was better than simvastatin alone in reducing arterial plaque in a group of patients with severe genetic high cholesterol. It wasn’t, and publication of the study set off a [...]
Posted in Regulatory | Also tagged , , , , , | 1 Comment

Merck to Axe 7,200 Positions

By George Koroneos | Published: October 22, 2008
Not much in the way of good news at Merck this morning. The pharma giant announced that it is revising its financial guidelines through 2010, and eliminating 7,200 positions by 2011. The move is expected to save the company $3.8 billion to $4.2 billion through 2013. The layoffs will be staggered throughout different parts of the [...]
Posted in Sales, Strategy | Also tagged , , , , , | Leave a comment

Moving On + Up

By Brittany Agro | Published: September 26, 2008
Promotions and hires for September 26, 2008: Merck named Barry J. Goldstein, M.D., vice president of clinical development for diabetes and obesity Sanofi-Aventis announced that Chris Viehbacher will succeed current CEO Gerard Le Fur in December GlaxoSmithKline named Ellen Strahlman chief medical officer Questcor Pharmaceuticals appointed Gary Sawka CFO Encorium appointed David Ginsberg president and CEO Wyeth named Daniel J. [...]
Posted in People | Also tagged , , , , , , , , , , , , , , , , , | Leave a comment